FMO5 and inflammatory bowel disease: NCF2 is associated with susceptibility to IBD, with studies indicating that mutations in NCF2 may alter NADPH oxidase activity and ROS production, potentially causing immune system overreaction or dysfunction, leading to chronic intestinal inflammation in IBD [36,37,38].